You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ESPR Disposition Disclosure
Harlow John B. Jr. · SEC Form 4 · Filed Jul 13, 2026
Disposition
Reported value range
Not reported
Harlow John B. Jr. Chief Commercial Officer
ESPR
Transaction date
Jul 13, 2026
Public filing date
Jul 13, 2026
Filing lag
Filed same day
ESPR daily price context
Close on/before transaction
$3.2
Jul 13, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 424,536 shares
- SEC ownership
- Direct
- Transaction code
- D
- Form
- 4
- Filing identifier
- 0001628280-26-048003
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
Not reported
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Esperion Therapeutics, Inc. ESPR Current | Disposition | Jul 13, 2026 | Not reported |